Matthew James Ware

Matthew James Ware

Auto-generated profile, based on publicly available information

Matthew James Ware

Department of Surgery, Baylor College of Medicine, Houston, TX, 77030, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2016 in Tissue Engineering Part C: Methods
Verified
Journal Article
Closed access
MWMatthew James Ware
Matthew James Ware
KCKevin Colbert
Kevin Colbert
VKVazrik Keshishian
Vazrik Keshishian
JHJason Chak-Shing Ho
Jason Chak-Shing Ho
SCStuart James Corr
Stuart James Corr
Biana GodinBiana Godin
Biana Godin
In vitro characterization of tumor cell biology or of potential anticancer drugs is usually performed using tumor cell lines cultured as a monolayer. However, it has been previously shown that three-dimensional (3D) organization of the tumor cells is important to provide insights on tumor biology and transport of therapeutics. Several methods to create 3D tumors in vitro have been proposed, with hanging drop technique being the most simple and, thus, most frequently used. However, in many cell lines this method has failed to form the desired 3D tumor structures. The aim of this study was to design and test an easy-to-use and highly reproducible modification of the hanging drop method for tumor sphere formation by adding methylcellulose polymer. Most pancreatic cancer cells do not form cohesive and manageable spheres when the original hanging drop method is used, thus we investigated these cell lines for our modified hanging drop method. The spheroids produced by this improved technique were analyzed by histology, light microscopy, immunohistochemistry, and scanning electron microscopy. Results show that using the proposed simple method; we were able to produce uniform spheroids for all five of the tested human pancreatic cancer cell lines; Panc-1, BxPC-3, Capan-1, MiaPaCa-2, and AsPC-1. We believe that this method can be used as a reliable and reproducible technique to make 3D cancer spheroids for use in tumor biology research and evaluation of therapeutic responses, and for the development of bio-artificial tissues.

1 November 2016 in Biomaterials
Verified
Journal Article
Closed access
MWMatthew J. Ware
Matthew J. Ware
VKVazrik Keshishian
Vazrik Keshishian
JLJustin J. Law
Justin J. Law
JHJason C. Ho
Jason C. Ho
CFCarlos A. Favela
Carlos A. Favela
SCSteven A. Curley
Steven A. Curley

16 June 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
FLFransisca Leonard
Fransisca Leonard
LCLouis T. Curtis
Louis T. Curtis
MWMatthew James Ware
Matthew James Ware
TNTaraz Nosrat
Taraz Nosrat
XLXuewu Liu
Xuewu Liu
Biana GodinBiana Godin
Biana Godin
Therapies targeted to the immune system, such as immunotherapy, are currently shaping a new, rapidly developing branch of promising cancer treatments, offering the potential to change the prognosis of previously non-responding patients. Macrophages comprise the most abundant population of immune cells in the tumor microenvironment (TME) and can undergo differentiation into functional phenotypes depending on the local tissue environment. Based on these functional phenotypes, tumor associated macrophages (TAM) can either aid tumor progression (M2 phenotype) or inhibit it (M1 phenotype). Presence of M2 macrophages and a high ratio of M2/M1 macrophages in the tumor microenvironment are clinically associated with poor prognosis in many types of cancers. Herein, we evaluate the effect of macrophage phenotype on the transport and anti-cancer efficacy of albumin-bound paclitaxel (nAb-PTX) loaded into porous silicon multistage nanovectors (MSV). Studies in a co-culture of breast cancer cells (3D-spheroid) with macrophages and in vivo models were conducted to evaluate the therapeutic efficacy of MSV-nAb-PTX as a function of macrophage phenotype. Association with MSV increased drug accumulation within the macrophages and the tumor spheroids, shifting the inflammation state of the TME towards the pro-inflammatory, anti-tumorigenic milieu. Additionally, the treatment increased macrophage motility towards cancer cells, promoting the active transport of therapeutic nanovectors into the tumor lesion. Consequently, apoptosis of cancer cells was increased and proliferation decreased in the MSV-nAb-PTX treated group as compared to controls. The results also confirmed that the tested system shifts the macrophage differentiation towards an M1 phenotype, possessing an anti-proliferative effect towards the breast cancer cells. These factors were further incorporated into a mathematical model to help analyze the synergistic effect of the macrophage polarization state on the efficacy of MSV-nAb-PTX in alleviating hypo-vascularized tumor lesions. In conclusion, the ability of MSV-nAb-PTX to polarize TAM to the M1 phenotype, causing (1) enhanced penetration of the drug-carrying macrophages to the center of the tumor lesion and (2) increased toxicity to tumor cells may explain the increased anti-cancer efficacy of the system in comparison to nAb-PTX and other controls.

13 June 2014 in ACS Nano
Verified
Journal Article
Open access
MWMatthew J. Ware
Matthew J. Ware
Biana GodinBiana Godin
Biana Godin
NSNeenu Singh
Neenu Singh
RMRavish Majithia
Ravish Majithia
SSSabeel Shamsudeen
Sabeel Shamsudeen
HSHuw Summers
Huw Summers
Understanding the effect of variability in the interaction of individual cells with nanoparticles on the overall response of the cell population to a nanoagent is a fundamental challenge in bionanotechnology. Here, we show that the technique of time-resolved, high-throughput microscopy can be used in this endeavor. Mass measurement with single-cell resolution provides statistically robust assessments of cell heterogeneity, while the addition of a temporal element allows assessment of separate processes leading to deconvolution of the effects of particle supply and biological response. We provide a specific demonstration of the approach, in vitro, through time-resolved measurement of fibroblast cell (HFF-1) death caused by exposure to cationic nanoparticles. The results show that heterogeneity in cell area is the major source of variability with area-dependent nanoparticle capture rates determining the time of cell death and hence the form of the exposure–response characteristic. Moreover, due to the particulate nature of the nanoparticle suspension, there is a reduction in the particle concentration over the course of the experiment, eventually causing saturation in the level of measured biological outcome. A generalized mathematical description of the system is proposed, based on a simple model of particle depletion from a finite supply reservoir. This captures the essential aspects of the nanoparticle–cell interaction dynamics and accurately predicts the population exposure–response curves from individual cell heterogeneity distributions.

13 July 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MWMatthew J. Ware
Matthew J. Ware
STSophia Tinger
Sophia Tinger
KCKevin L. Colbert
Kevin L. Colbert
SCStuart J. Corr
Stuart J. Corr
PRPaul Rees
Paul Rees
Biana GodinBiana Godin
Biana Godin
The importance of evaluating physical cues in cancer research is gradually being realized. Assessment of cancer cell physical appearance, or phenotype, may provide information on changes in cellular behavior, including migratory or communicative changes. These characteristics are intrinsically different between malignant and non-malignant cells and change in response to therapy or in the progression of the disease. Here, we report that pancreatic cancer cell phenotype was altered in response to a physical method for cancer therapy, a non-invasive radiofrequency (RF) treatment, which is currently being developed for human trials. We provide a battery of tests to explore these phenotype characteristics. Our data show that cell topography, morphology, motility, adhesion and division change as a result of the treatment. These may have consequences for tissue architecture, for diffusion of anti-cancer therapeutics and cancer cell susceptibility within the tumor. Clear phenotypical differences were observed between cancerous and normal cells in both their untreated states and in their response to RF therapy. We also report, for the first time, a transfer of microsized particles through tunneling nanotubes, which were produced by cancer cells in response to RF therapy. Additionally, we provide evidence that various sub-populations of cancer cells heterogeneously respond to RF treatment.

26 August 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SCStuart J. Corr
Stuart J. Corr
SSSabeel Shamsudeen
Sabeel Shamsudeen
LVLeoncio A. Vergara
Leoncio A. Vergara
JHJason Chak-Shing Ho
Jason Chak-Shing Ho
MWMatthew J. Ware
Matthew J. Ware
RSRita E. Serda
Rita E. Serda
Herein, we present a novel imaging platform to study the biological effects of non-invasive radiofrequency (RF) electric field cancer hyperthermia. This system allows for real-time in vivo intravital microscopy (IVM) imaging of radiofrequency-induced biological alterations such as changes in vessel structure and drug perfusion. Our results indicate that the IVM system is able to handle exposure to high-power electric-fields without inducing significant hardware damage or imaging artifacts. Furthermore, short durations of low-power (< 200 W) radiofrequency exposure increased transport and perfusion of fluorescent tracers into the tumors at temperatures below 41°C. Vessel deformations and blood coagulation were seen for tumor temperatures around 44°C. These results highlight the use of our integrated IVM-RF imaging platform as a powerful new tool to visualize the dynamics and interplay between radiofrequency energy and biological tissues, organs, and tumors.